Proteasome-mediated regulation of CPG DNA- and peptidoglycan-induced cytokines, inflammatory genes, and mitogen-activated protein kinase activation

Shock

Volumn 25, Issue 6, 2006, Pages 594-599

  Shen, Jing ^a   Gao, Jian Jun ^a   Zhang, Guochi ^a   Tan, Xiaoyu ^a   Morrison, David C ^a   Papasian, Christopher ^a   Vogel, Stefanie N ^b   Qureshi, Nilofer ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CpG DNA; Lipopolysaccharide; Peptidoglycan; Proteasome

Indexed keywords

BACTERIAL DNA; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; I KAPPA B; INTERLEUKIN 1BETA; LACTACYSTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDOGLYCAN; PROTEASOME; PROTEASOME INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; ACETYLCYSTEINE; CYSTEINE PROTEINASE INHIBITOR; DRUG DERIVATIVE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FUNCTIONAL PROTEOMICS; GENE EXPRESSION REGULATION; GENETIC REGULATION; IMMUNOREGULATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; INFLAMMATION; METABOLISM;

ACETYLCYSTEINE; ANIMALS; CELL LINE; CPG ISLANDS; CYSTEINE PROTEINASE INHIBITORS; CYTOKINES; DNA, BACTERIAL; GENE EXPRESSION REGULATION; INFLAMMATION; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; PEPTIDOGLYCAN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-TYROSINE KINASES; TRANSCRIPTION FACTOR AP-1;

EID: 33745629870     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000209555.46704.2d     Document Type: Article

References (29)

1. Dziarski R, Tapping RI, Tobias PS: Binding of bacterial peptidoglycan to CD14. J Biol Chem 273:8680-8690, 1998.
2. Dziarski R: Recognition of bacterial peptidoglycan by innate immune system. Cell Mol Life Sci 60:1793-1804, 2003.
3. Krieg AM: CpG motifs in bacterial DNA and their immune effects. Ann Rev Immunol 20:709-760, 2002.
4. Lipford GB, Heeg K, Wagner H: Bacterial DNA as immune cell activator. Trends Microbiol 6:496-500, 1998.
5. Gao JJ, Zuvanich EG, Xue Q, Horn DL, Silverstein R, Morrison DC: Bacterial DNA and lipopolysaccharide act in synergy in inducing NO production in RAW 264.7 macrophages. J Immunol 163:4095-4099, 1999.
6. Oberholzer A, Oberholzer C, Moldawar LL: Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83-96, 2001.
7. Pruitt JH, Copeland EM III, Moldawar LL: Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 3:235-251, 1995.
8. Turnbull IR, Javadi P, Buchman TG, Hotchkiss RS, Karl IE, Coopersmith CM: Antibiotics improve survival in sepsis independent of injury but do not change mortality in mice with markedly elevated interleukin 6 levels. Shock 21:121-125, 2004.
9. Zingarelli B, Halusha PV, Caputi AP, Cook JA: Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 3:102-108, 1995.
10. Shieh P, Zhou M, Ornan DA, Chaudry IH, Wang P: Upregulation of inducible nitric oxide synthase and nitric oxide occurs later than the onset of the hyperdynamic response during sepsis. Shock 13:325-329, 2000.
11. Gao JJ, Diesl V, Witmann T, Morrison DC, Ryan JL, Vogel SN, Follettie MT: Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J Leuk Biol 72:1234-1245, 2002.
12. Vogel SN, Fitzerald KA, Fenton MJ: Toll receptors. Mol Interv 3:466, 2003.
13. Schwander R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan and lipotechoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274:17406-17409, 1999.
14. Nakao Y, Funami K, Kikkawa S, Taniguchi M, Nishiguchi M, Fukumori Y, Seya T, Matsumoto M: Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J Immunol 174:1566-1573, 2005.
15. Travassos LH, Girardin SE, Philpott DJ, Blanot D, Nahori M-A, Werts C, Boneca IG: Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 5:1000-1006, 2004.
16. Kisselev AF, Goldberg AL: Proteasome inhibitors from research tools to drug candidates. Chem Biol 8:739-758, 2001.
17. Wolf DH: Proteasome: a historical retrospective. In Hilt W, Wolf DH (eds.): Proteasomes: The World of Regulatory Proteolysis. Georgetown, TX: Landes Bioscience, pp 1-7, 2000.
18. Hershko A: Review: Nobel Lecture. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ 12:1191-1197, 2005.
19. Ciechanover A: Review: Nobel Lecture. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Cell Death Differ 12:1178-1190, 2005.
20. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL: Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731, 1995.
21. Fenteany G, Schreiber SL: Lactacystin, proteasome function, and cell fate. J Biol Chem 273:8545-8548, 1998.
22. Qureshi N, Perera P-Y, Shen J, Zhang G, Lenschat A, Splitter G, Morrison DC, Vogel SN: The proteasome as a LPS-binding protein in macrophages. Differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events. J Immunol 171:1515-1525, 2003.
23. Qureshi N, Vogel SN, Van Way C III, Papasian CJ, Qureshi AA, Morrison DC: The proteasome: a central regulator of inflammation and macrophage function. Immunologic Res 31/3:243-260, 2004.
24. Shen J, Reis J, Morrison DC, Papasian C, Raghavakaimal S, Kolbert C, Qureshi A, Vogel SN, Qureshi N. Key inflammatory signaling pathways are regulated by the proteasome. Shock. In press.
25. Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277, 1986.
26. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV: Implications of proteasome inhibition: an enhanced macrophage phenotype. Cell Immunol 227:140-147, 2004.
27. Hipp MS, Urbich C, Mayer P, Wischhusen J, Weller M, Kracht M, Spyridopoulous I: Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. Eur J Immunol 32:2208-2017, 2002.
28. Hacker H, Mischak H, Miethke T, Lipstay S, Schmid R, Sparwasser T, Heeg K, Lipford GB, Wagner H: CpG-DNA-specific activation of antigen presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 17:6230-6240, 1998.
29. Yi A-K, Krieg AM: Cutting edge: rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol 161:4493-4497, 1998.